Patents by Inventor Norbert Brock

Norbert Brock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • oxazaphosphorin-4-thio alkanesulphonic acids, neutral salts thereof and method to treat cancer diseases and to produce immunosuppression
    Patent number: 4929607
    Abstract: This invention relates to new oxzaphosphorin-4-thio-alkanesulphonic acids and to the neutral salts thereof corresponding to the general formula I ##STR1## and to methods to use such compounds to treat cancer diseases and to produce immunosuppression in humans and animals.
    Type: Grant
    Filed: February 2, 1988
    Date of Patent: May 29, 1990
    Assignee: ASTA Pharma Aktiengesellshaft
    Inventors: Gerhard Scheffler, Ulf Niemeyer, Norbert Brock, Jorg Pohl
  • Oxazaphosphorin-4-thio-alkanesulphonic acids, and neutral salts thereof
    Patent number: 4623742
    Abstract: This invention relates to new oxazaphosphorin-4-thio-alkanesulphonic acids and to the neutral salts thereof corresponding to the general formula I ##STR1## and to methods to use such compounds to control cancer diseases and to produce immunosuppression in humans and animals.
    Type: Grant
    Filed: December 19, 1984
    Date of Patent: November 18, 1986
    Assignee: ASTA-Werke Aktiengesellschaft Chemische Fabrik
    Inventors: Gerhard Scheffler, Ulf Niemeyer, Norbert Brock, Jorg Pohl
  • 4-carbamoyloxy-oxazaphosphorins
    Patent number: 4618692
    Abstract: The present invention relates to new 4-carbamoyloxy-oxazaphosphorins of the general Formula I ##STR1## as well as to a method for the treatment of malign tumor diseases in humans using such compounds as active agent.
    Type: Grant
    Filed: February 13, 1984
    Date of Patent: October 21, 1986
    Assignee: Asta-Werke Aktiengesellschaft
    Inventors: Gerhard Scheffler, Ulf Niemeyer, Norbert Brock, Jorg Pohl
  • Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
    Patent number: 4220660
    Abstract: The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a mercapto alkane sulfonic acid having the general formulaHS--alk--SO.sub.3 4to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the mercapto alkane sulfonic acid, simultaneously or separately in combination with the alkylating agent.
    Type: Grant
    Filed: December 6, 1978
    Date of Patent: September 2, 1980
    Assignee: Asta-werke Aktiengesellschaft, Chemische Farik
    Inventor: Norbert Brock
  • Process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents
    Patent number: 4218471
    Abstract: The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic acid) having the general formula ##STR1## to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the dithiodi-(alkane sulfonic acid), simultaneously or separately in combination with the alkylating agent.
    Type: Grant
    Filed: February 6, 1979
    Date of Patent: August 19, 1980
    Assignee: Asta-Werke Aktiengesellschaft Chemische Fabrik
    Inventors: Norbert Brock, Jurij Stekar
  • Process for the treatment of spasmodic conditions in humans
    Patent number: 4124716
    Abstract: Process for the treatment of spasmodic conditions in humans by administering a compound of the general formula ##STR1## or a pharmacologically acceptable acid addition salt thereof to a human suffering from such conditions.
    Type: Grant
    Filed: October 14, 1977
    Date of Patent: November 7, 1978
    Assignee: Asta-werke Aktiengesellschaft
    Inventors: Peter Emig, Hans Pohle, Gerhard Scheffler, Norbert Brock, Hans-Dieter Lenke, Jorg Pohl
  • Basic enol ether and acid addition salts thereof
    Patent number: 4065501
    Abstract: The present invention is related to new basic enol ethers having the general formula ##STR1## and to the pharmacologically acceptable acid addition salts thereof. The invention is further related to process for the treatment of spasmodic conditions in humans by administering a compound of the above general formula or a pharmacologically acceptable acid addition salt thereof to a human suffering from such conditions.
    Type: Grant
    Filed: March 12, 1975
    Date of Patent: December 27, 1977
    Assignee: Asta-Werke Aktiengesellschaft
    Inventors: Peter Emig, Hans Pohle, Gerhard Scheffler, Norbert Brock, Hans-Dieter Lenke, Jorg Pohl